NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/01/2024
Back to search
Official data from USPTO
FLORATEK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
11/01/2024
Trademark type
Word
Nice classes
5, 42
Filing date
10/13/2021
Registration date
06/06/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/06/2023
Last transaction
06/06/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
Aubonne, CH
Examiner
CANTOR, JILLIAN
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Floratek Pharma SA
Representatives
Diane B. Melnick Practus LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparationsnamely a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; medicinal preparations for the treatment of infectious diseases and for use in oncology; therapeutic preparations for treating cardiovascular diseases; pharmaceutical and medicinal preparations and substances for the treatment of diabetes; pharmaceutical and medicinal preparations and substances for use in oncology; pharmaceutical and medicinal preparationssubstances and compositions for the treatment and/or prevention of cancer; pharmaceutical and medicinal preparations and substances for the treatment of neurodegenerative disorders; pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases
Class 42
Scientific research; pharmaceutical research; medical research services in the field of medicines; technical advice for third parties in the field of development of pharmaceutical products; product development for third parties in the field of pharmaceutical products; research and development of pharmaceuticals and medicinal preparations and substances for third parties; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of cancer; research and development of pharmaceuticals and medicinal preparations and substances for treating inflammation; research and development of pharmaceuticals and medicinal preparations and substances for the treatment of neurodegenerative disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders; research and development of pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis; research and development of pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases
Publications
History of USPTO decisions and trademark events.
31 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/06/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/07/2023
FIMP
FINAL DISPOSITION PROCESSED
09/07/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/17/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/17/2023
GPNX
NOTIFICATION PROCESSED BY IB
03/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2023
PUBO
PUBLISHED FOR OPPOSITION
03/21/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/01/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/05/2023
RFNT
REFUSAL PROCESSED BY IB
08/29/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/11/2022
RFRR
REFUSAL PROCESSED BY MPU
08/11/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/21/2022
CNRT
NON-FINAL ACTION WRITTEN
07/20/2022
DOCK
ASSIGNED TO EXAMINER
07/19/2022
MAFR
APPLICATION FILING RECEIPT MAILED
12/24/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/20/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/16/2021
Continuous trademark protection
Get notified about every new filing that threatens FLORATEK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.